$AVAX — tbh, I keep coming back to how it has not invalidated the long case. The price successfully reclaimed the prior short-term swing low, and the daily bias remains bullish. A strong bullish rejection near the range floor shows buyers stepping up on the shorter timeframes. This trade gets more conviction if we see a decisive close above the recent short-term swing high.
A clean invalidation ends the thesis — no averaging into it.
Execution plan (AVAXUSDT — LONG)
Entry: 10.468 - 10.518 | SL: 10.363
Take profit: 10.623 → 10.727 → 10.858
#TechnicalAnalysis
A clean invalidation ends the thesis — no averaging into it.
Execution plan (AVAXUSDT — LONG)
Entry: 10.468 - 10.518 | SL: 10.363
Take profit: 10.623 → 10.727 → 10.858
#TechnicalAnalysis


